Biotech Implosion: Favrille (FVRL)
Favrille, Inc. (NASDAQ: FVRL) may have just joined the realm of biotech zombies this morning, or close to it. The company announced Phase III results which failed to show statistically significant...
View ArticlePharmacyclics Scores on Non-Hodgkins Lymphoma Data (PCYC)
Pharmacyclics Inc. (NASDAQ: PCYC) is seeing shares surge today after it said that its Phase 1/2 trial of motexafin gadolinium plus antibody targeted radiation therapy demonstrated a high complete...
View ArticleAnti-Cancer Vaccine Data Creates Two Huge Moves (BVTI, ABPI)
There are two tiny stocks that are benefiting from some positive Phase III data on an anti-cancer vaccine. Biovest International, Inc. (OTCBB: BVTI) is a majority-owned subsidiary of Accentia...
View ArticleNon-Hodgkins Lymphoma Vaccine Shows Promise (ABPI, BVTI)
Biovest International, Inc. (OTCBB:BVTI) is a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI). This morning the company has what appears to be some very positive cancer...
View Article
